Isoagglutinin removal by plasma centrifugation or filtration (single or double): A prospective study in a single center
- PMID: 33230824
- DOI: 10.1002/jca.21857
Isoagglutinin removal by plasma centrifugation or filtration (single or double): A prospective study in a single center
Abstract
Introduction: ABO-incompatible (ABOi) kidney transplantation, a well-established procedure, has good long-term results provided pretransplant desensitization that includes immunosuppression and apheresis.
Objective: To compare, within the first pretransplant apheresis session given to 29 ABOi kidney-transplant candidates, the effect on isoagglutinin titers (both IgG and IgM isotypes) of three modalities: centrifugation therapeutic plasmapheresis (cTP; n = 10), filtration TP (fTP; n = 9), and double-filtration plasmapheresis (DFPP; n = 10).
Results: The three groups were comparable according to baseline demographics. Treated plasma volumes were similar across the three groups, that is, 4111 ± 403 mL (cTP), 3861 ± 282 mL (fTP), and 3699 ± 820 mL (DFPP): that is, 54 ± 7, 53 ± 7, and 53 ± 10 mL/kg respectively. One session of centrifugation or filtration TP reduced IgG anti-A/anti-B isoagglutinin titer by ~4, whereas one DFPP session reduced it by ~2. One session of cTP reduced IgM anti-A isoagglutinin titer by a little less than 4, whereas fTP and DFPP sessions reduced it by ~3. There were no statistical differences across the three groups regarding isoagglutinin rebound (IgG and IgM). However, isoagglutinin IgG rebound was >4 dilutions for anti-B titers compared with ~2 dilutions for anti-A titers. The median decreases in IgG level were -3.9 g/L (DFPP), -5.9 g/L (cTP), and - 6.06 g/L (fTP) (p = ns). Median fibrinogen depletions were ~ 60% (fTP), 64% (DFPP), and 76% (cTP).
Conclusions: Isoagglutinin depletions within the first apheresis session were similar across cTP, fTP, and DFPP: this was numerically lower for DFPP.
Keywords: ABO incompatible; centrifugation plasmapheresis; double-filtration plasmapheresis; filtration plasmapheresis; kidney transplantation.
© 2020 Wiley Periodicals LLC.
Similar articles
-
Comparative study of theefficacy of removal of anti-ABO and anti-gal antibodies by double filtration plasmapheresis.Xenotransplantation. 2000 May;7(2):101-8. doi: 10.1034/j.1399-3089.2000.00063.x. Xenotransplantation. 2000. PMID: 10961294
-
Comparing the efficacy of three techniques to reduce isoagglutinin titers in AB0 incompatible kidney transplant recipients.Atheroscler Suppl. 2017 Nov;30:253-256. doi: 10.1016/j.atherosclerosissup.2017.05.017. Epub 2017 Jun 1. Atheroscler Suppl. 2017. PMID: 29096846
-
Double-filtration plasmapheresis.Transplantation. 2007 Dec 27;84(12 Suppl):S30-2. doi: 10.1097/01.tp.0000296103.34735.b8. Transplantation. 2007. PMID: 18162985
-
Removal of anti-A/B antibodies for successful kidney transplantation between ABO blood type incompatible couples.Transfus Sci. 1996 Sep;17(3):455-62. doi: 10.1016/0955-3886(96)00029-x. Transfus Sci. 1996. PMID: 10163554 Review.
-
Pleiotropic effects of double filtration plasmapheresis.Ther Apher Dial. 2024 Dec;28(6):825-829. doi: 10.1111/1744-9987.14194. Epub 2024 Sep 8. Ther Apher Dial. 2024. PMID: 39245561 Review.
Cited by
-
Plasma exchange in the intensive care unit: a narrative review.Intensive Care Med. 2022 Oct;48(10):1382-1396. doi: 10.1007/s00134-022-06793-z. Epub 2022 Aug 12. Intensive Care Med. 2022. PMID: 35960275 Free PMC article. Review.
References
REFERENCES
-
- Nakanishi T, Suzuki N, Kuragano T, Nagasawa Y, Hasuike Y. Current topics in therapeutic plasmapheresis. Clin Exp Nephrol. 2014;18(1):41-49. https://doi.org/10.1007/s10157-013-0838-0.
-
- Alamartine E, Maillard N. Therapeutic plasma exchange in nephrology. Where it applies? Transfus Apher Sci. 2019;58(3):262-265. https://doi.org/10.1016/j.transci.2019.04.010.
-
- Hirano R, Namazuda K, Suemitsu J, Harashima T, Hirata N. Plasma separation using a membrane. Transfus Apher Sci. 2017;56(5):649-653. https://doi.org/10.1016/j.transci.2017.08.008.
-
- Maggioni S, Allal A, Kamar N, Hermelin M, Faubel E, Rostaing L. Immunoadsorption and hemodialysis as a tandem procedure: a single-center experience of more than 60. Int J Artif Organs. 2015;38(6):304-310. https://doi.org/10.5301/ijao.5000420.
-
- Takahashi K, Saito K. ABO-incompatible kidney transplantation. Transplant Rev (Orlando). 2013;27(1):1-8. https://doi.org/10.1016/j.trre.2012.07.003.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous